Nectin Therapeutics Revenue

Biotechnology Research • West Jerusalem, Jerusalem District, Israel • 11-20 Employees

Nectin Therapeutics revenue & valuation

Annual revenue	$1,500,000
Revenue per employee	$137,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,800,000
Total funding	$10,000,000

Key Contact at Nectin Therapeutics

Pini Tsukerman

Co-Founder & Cso

Company overview

Headquarters	West Jerusalem, Jerusalem District, Israel
Phone number	+972544247524
Website	nectintx.com
SIC	283
Founded	2017
Employees	11-20
Socials

Nectin Therapeutics Email Formats

Nectin Therapeutics uses 3 email formats. The most common is {first initial} (e.g., j@nectintx.com), used 60% of the time.

Format	Example	Percentage
{first initial}	j@nectintx.com	60%
{first name}	john@nectintx.com	30%
{first initial}.{last name}	j.doe@nectintx.com	10%

About Nectin Therapeutics

Nectin Therapeutics is a biotech company focused on unlocking the power of the immune system. We are developing a collection of next-generation immunotherapy agents. Despite the unprecedented efficacy of existing immunotherapy agents, many patients either fail to respond, or following encouraging initial response, develop resistance over time. At Nectin, we have discovered novel resistance mechanisms and developed novel agents targeting these mechanisms for improved therapy. At Nectin, we are dedicated to the development of novel therapeutic options for cancer patients. We are developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, we develop CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Nectin Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Nectin Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-06	1	$10,000,000

Funding Insights

$10,000,000

Total funding amount

$10,000,000

Most recent funding amount

Number of funding rounds

Nectin Therapeutics Tech Stack

Discover the technologies and tools that power Nectin Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Autoptimize

Performance

reCAPTCHA

Security

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Frequently asked questions

Nectin Therapeutics is located in West Jerusalem, Jerusalem District, IL.

You can reach Nectin Therapeutics at +972544247524.

Nectin Therapeutics generates an estimated annual revenue of $1,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Nectin Therapeutics has an estimated valuation of $4,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Nectin Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Nectin Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Nectin Therapeutics has raised a total of $10,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Nectin Therapeutics

Pini Tsukerman

Co-Founder & Cso

4.8

40,000 users